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BACKGROUND: Since the growth state of macrophages
in local pathological sites is considered a factor that
regulates the processes of many disease, such as
tumors, inflammation, and atherosclerosis, the sub-
stances that regulate macrophage growth or survival
may be useful for disease control. We previously
reported that securiosides A and B, novel triterpene
saponins, exerted macrophage-oriented cytotoxicity
in the presence of a L-cell-conditioned medium
containing macrophage colony-stimulating factor
(M-CSF), while the compounds did not exhibit an
effect on macrophages in the absence of the growth-
stimulating factors.
Aim: This study was undertaken to characterize the
growth-inhibitory and the apoptosis-inducing activ-
ities of securioside B, focusing on the effects of the
macrophage-growth factor(s), and to examine the
implication of a mitochondria pathway in apoptosis
induction.
Methods: The effect of securioside B on a murine
macrophage cell line (BAC1.2F5) was examined by
MTT assay and lactose dehydrogenase release assay in
the presence of L-cell-conditioned medium, M-CSF, or
granulocyte 
/macrophage CSF (GM-CSF).
Results: Securioside B inhibited the growth of the
cells stimulated by recombinant M-CSF or GM-CSF,
but it scarcely induced cytolysis of the cells under the
same conditions. Moreover, securioside B did not
induce cell death when the compound only was
added to the cells. On the other hand, the compound
extensively induced apoptotic cell death in the
presence of L-cell-conditioned medium, suggesting
that apoptosis induction by securioside B requires
the additional factor(s) present in L-cell-conditioned
medium. Securioside B plus L-cell-conditioned med-
ium induced the activation of caspase-3 and caspase-
9, but not caspase-8. In addition, cytochrome c
release from the mitochondria into the cytosol, and
disrupted mitochondria membrane potential, was
also observed in the apoptotic BAC1.2F5 cells.
Conclusion: These data suggest that securioside B has
growth-inhibitory activity against growth factor-sti-
mulated macrophages, and that it induces apoptotic
macrophage death through the activation of a
mitochondrial pathway in the presence of L-cell-
conditioned medium.
Key words: Macrophages, Growth inhibition, Apoptosis,
Securioside B, BAC1.2F5 cells, L-cell-conditioned medium,
M-CSF, GM-CSF
Mediators of Inflammation, 12(3), 157 /166 (June 2003)
Characterization of the growth-
inhibitory and apoptosis-inducing
activities of a triterpene saponin,
securioside B against BAC1.2F5
macrophages
Satoru Yui
1,CA, Tomoya Kudo
1, Kazumi Hodono
1,
Yoshihiro Mimaki
2, Minpei Kuroda
2,
Yutaka Sashida
2 and Masatoshi Yamazaki
1
1Faculty of Pharmaceutical Sciences, Teikyo
University, 1091-1 Sagamiko, Tsukui-gun, Kanagawa
199-0195, Japan;
2Laboratory of Medicinal Plant
Science, School of Pharmacy, Tokyo University of
Pharmacy and Life Science, Horinouchi, Hachioji,
Tokyo, Japan
CACorresponding author
Tel:   /81 426 85 3736
Fax:   /81 426 85 2574
E-mail: sat-yui@pharm.teikyo-u.ac.jp
Introduction
Macrophages play roles in regulating the pathological
processes of many diseases, such as tumors, inflam-
matory diseases, and atherosclerosis, through the
production of various cytokines, enzymes, and
reactive oxygen intermediates.
1,2 There are cumula-
tive observations that the local proliferation of
macrophages occurs in tumors,
3,4 atherosclerotic
lesions,
5 8 and inflammatory sites,
9,10 to expand
macrophage accumulation, and the proliferation is
thought to influence each pathological process.
The growth of peripheral macrophages is induced
by protein factors, macrophage colony-stimulating
factor (M-CSF/CSF-1), and granulocyte /macrophage
colony-stimulating factor (GM-CSF).
11 13 We re-
ported that phagocytosed materials by macrophages,
such as effete cells, denatured lipoproteins, and
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157ligands of scavenger receptors, induce macrophage
growth in the mediation of GM-CSF production by
macrophages themselves.
14 17 M-CSF/CSF-1 and GM-
CSF may affect the disease process by modulating
macrophage function in addition to inducing growth.
CSF-1 expression in tumors reportedly promotes the
metastatic character of the tumor cells, possibly by
functionally altered macrophages.
18
Both the local accumulation of macrophages in the
local pathological sites and their activation states are
considered to influence the regulatory activity of this
cell type. In other words, the quantitative aspect of
macrophages is important for the regulatory function,
as well as the qualitative aspect of macrophages;
namely, their activation state or cytokine-producing
activity. Accordingly, to find substances that have
growth-inhibiting or apoptosis-inducing activity to-
wards macrophages stimulated by macrophage
growth factors, may be useful for the regulation of
many diseases.
Several substances, such as liposome-encapsulated
bisphosphonate clodronate, were developed for the
depletion of macrophages.
19 However, the effect of
this drug is thought to be non-specific to macro-
phages with various growth and activation states: the
inhibiting substances or apoptosis-inducing sub-
stances oriented to macrophages, stimulated by
macrophage growth factors, are needed for a more
subtle suppression of macrophages.
We previously reported that triterpene saponins,
securiosides A and B, purified from the extract of
Securidaca inappendiculata, showed growth-inhi-
biting and apoptosis-inducing activity against murine
inflammatory macrophages in the presence of L-cell-
conditioned medium,
20,21 which is a source of M-
CSF.
11 The structural difference between securiosides
A and B is within their sugar chains.
20 The com-
pounds did not interfere with the growth of other cell
types, such as EL-4 lymphoma and L-929 fibrosar-
coma cells, at the same concentration that they
exerted growth inhibitory and cytotoxic activity
against the cultured macrophages. Moreover, the
compounds did not alter the viability of the macro-
phages in the absence of L-cell-conditioned medium
and a macrophage-like cell line (J774.1), suggesting
that they act preferably on macrophages stimulated
by M-CSF or other factors existing in L-cell-condi-
tioned medium.
21 Although we preliminarily ob-
served that securiosides showed cytotoxicity against
macrophages with M-CSF in an MTT assay,
21 it is still
unknown whether the compounds induce not only
growth inhibition, but also apoptosis against macro-
phages treated with M-CSF or another macrophage
growth factor, GM-CSF. Accordingly, a more precise
study is required to characterize the growth-inhibit-
ing and cytotoxic activity of securiosides in respect to
the effect of macrophage growth factors. Also, the
intracellular pathways in apoptosis induction by
securiosides have not been explored.
In the present paper, we study the requirement of
macrophage growth factors for securiosides to induce
macrophage apoptosis, and explored the intracellular
mechanism of apoptosis induction, using BAC1.2F5
cells, a M-CSF-dependent macrophage cell line. We
used only securioside B for this analysis, since the
two securiosides have almost an equal activity for
macrophages cultured with L-cell-conditioned med-
ium.
20,21 The results show that securioside B exhib-
ited a growth-inhibitory effect on the BAC1.2F5 cells
in the presence of M-CSF or GM-CSF, but induced
apoptosis of the cells in the presence of L-cell-
conditioned medium, and that the compound acti-
vated a mitochondria pathway in the induction of
macrophage apoptosis.
Materials and methods
Reagents
Recombinant mouse M-CSF (rM-CSF) and recombi-
nant mouse GM-CSF (rGM-CSF) were purchased
from Genzyme (Cambridge, MA, USA). Anti-cas-
pase-3 (H-277, rabbit polyclonal) and anti-cyto-
chrome c (H-104, rabbit polyclonal) antibodies
were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Anti-caspase-8 (rabbit poly-
clonal) was purchased from Calbiochem-Novabio-
chem Corp. (San Diego, CA, USA). Anti-rabbit
immunoglobulin (Ig)G-horseradish peroxidase
(HRP) conjugate (goat polyclonal) was from Santa
Cruz. A caspase-family inhibitor, Z-VAD-FMK, was
purchased from Promega (Madison, WI, USA).
Securioside B
Securioside B was purified from the hot water
extracts of the dried roots of S. inappendiculata
Hassk as previously described.
20,21
Macrophages and cell counting
The BAC1.2F5 mouse macrophage cell line
22 was
kindly supplied by Dr E. R. Stanley (Albert Einstein
College of Medicine, New York) and was maintained
in RPMI 1640 medium (Nissui Seiyaku Co., Tokyo,
Japan), supplemented with 10% heated-inactivated
fetal calf serum (FCS) (Iwaki, Chiba, Japan), 100 U/ml
penicillin, 60 mg/ml Kanamycin, in the presence of
20% L-cell-conditioned medium, as a source of CSF-
1.
11 For the cytotoxicity assay for securioside B,
BAC1.2F5 cells in the exponential growth phase
were harvested by scraping with a rubber policeman,
and the cells were added to the wells of flat-bottomed
plates with RPMI 1640 medium, supplemented with
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‘medium’). L-cell-conditioned medium, M-CSF, or
GM-CSF were simultaneously added with securioside
B. The plates were cultured at 378C in a humidified
atmosphere of 5% CO2 until the cytotoxicity was
evaluated, as described later. Growth of the
BAC1.2F5 cells was evaluated by cell counting. The
cells were incubated in 24-well plates (Iwaki) at 1 /
10
5 cells/well in 1 ml medium, and the numbers of
adherent cells within five standard-sized areas (0.25
mm
2) in each of two wells were counted.
Mouse peritoneal macrophages were obtained 4
days after an intraperitoneal injection of 30 mg starch
into each C3H/He mouse (Japan SLC, Inc., Shizuoka,
Japan), and cultured as previously described.
21
Cytotoxicity assay
The cytotoxicity of securioside B towards the
BAC1.2F5 cells was evaluated by MTT assay.
23 The
cells were incubated in 96-well microplates (Iwaki) at
1 /10
4 cells/well. In the MTT assay, after the
indicated culture periods, 25 ml 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide
(MTT) (5 mg/ml) was added to each well, and the
plates were incubated for an additional 3 h. Then, 150
ml supernatant was discarded, 100 ml acid-isopropanol
solution (0.04 N HCl in 2-propanol) was added to
each well, and the optical density (588 nm) was
measured with a microplate reader (MTP-100; Corona
Electric, Ibaragi, Japan). Cytolytic activity was as-
sessed by a L-lactate dehydrogenase (LDH) release
assay, and LDH activity in the culture supernatants,
which were released from the cytosol of the damaged
cells, was measured using a CytoTox 96 Non-radio-
active cytotoxicity assay kit (Promega). LDH activity
in each residual cell was measured after solubilizing
the adherent cells with the solubilizing buffer from
the kit. Percent LDH release was calculated as follows:
% LDH release
 
LDH in supernatants
LDH in supernatants   LDH in residual cells
 100
Experiments were performed with triplicate determi-
nations in these assays.
DNA breaks
DNA breaks in the cultured BAC1.2F5 cells were
detected in situ by the terminal deoxynucleotidyl
transferase (TdT)-mediated dUTP nick end labeling
(TUNEL) method, which was originally described by
Gavrieli et al.
24 The BAC1.2F5 cells (2.4 /10
4 cells)
were cultured in eight-well Lab-Tek slide chambers
(Nalge Nunc International, Naperville, IL, USA) with
the indicated concentrations of L-cell-conditioned
medium and securioside B for 3 days. After the
damaged cells detached from the culture substrate
were removed by gentle washing with phosphate-
buffered saline (PBS) three times, the DNA breaks in
the adherent cells were detected by MEBSTEIN
Apoptosis Kit Direct (Medical and Biological Labora-
tories Co., Ltd., Nagoya, Japan). The TUNEL reaction
enzymatically labeled free 3?-OH termini of the DNA
strand breaks with fluorescein-dUTP with TdT. The
fluorescein incorporated into the cells was observed
by fluorescence microscopy.
Measurement of caspase activity
The caspase-3, caspase-8, and caspase-9 activities in
the cytosolic extracts of the BAC1.2F5 cells were
measured by a Caspase-3/CPP32 Colorimetric Pro-
tease Assay Kit, a Caspase-8/FLICE Colorimetric
Protease Assay Kit, and a Caspase-9/Mch6 Colori-
metric Protease Assay Kit (Medical and Biological
Laboratories Co.), respectively. Briefly, the cells (2 /
10
6 cells) in 100 mm dishes (Corning, Corning, NY,
USA) were cultured with 10 ml medium with the
indicated concentrations of L-cell-conditioned med-
ium and securioside B. After the indicated days, the
adherent cells were harvested by scrapping with a
rubber policeman. The cells were washed with PBS
twice and lysed with Cell lysis buffer (Medical and
Biological Laboratories Co.), and the supernatants
were obtained after centrifuging at 10,000 /g for 1
min. The protein concentrations of the cytosolic
extracts were determined by Bradford protein assay
(Pierce, Rockford, IL, USA) with bovine serum
albumin as a standard. The caspase-3, caspase-8 or
caspase-9 activities of each 100 mg protein extract
were assayed by the measurement of DEVD-pNa,
IETD-pNa, or LEHD-pNa cleavage, respectively.
Western blotting of procaspases
For the analysis of the processing of procaspase-3
and procaspase-8, treated cells were lysed as already
described and equal amounts of cytosolic extracts (10
mg protein/lane) were electrophoresed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) using precast gels (NPG-520L; Atto
Corp., Tokyo, Japan), and were transferred onto
polyvinyldifluoride (PVDF) membranes (Bio-Rad,
Hercules, CA, USA). Anti-caspase-3 and anti-cas-
pase-8 antibodies were used at dilutions of 1:200,
followed by incubation with anti-rabbit Ig-HRP. The
signal was visualized with an ECL kit (Amersham,
Arlington Heights, IL, USA).
Western blotting of cytosolic cytochrome c
The BAC1.2F5 cells (2 /10
6 cells/dish) were seeded
onto culture dishes (f /100 mm) and treated with
Cytotoxicity of securioside B against macrophages
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harvested as described, resuspended in ice cold
preparation buffer-1 [10 mM Tris /HCl, pH 7.5, 0.3
M sucrose, 10 mM each of aprotinin, pepstatin, and
leupeptin, and 1 mM phenylmethylsulfonylfluoride),
and homogenized using a Potter-type homogenizer
(Weaton, Millville, NJ, USA). The post-mitochondria
supernatants were obtained after centrifugation at
10,000 /g for 60 min at 48C. The supernatants (10
mg/lane) were resolved by SDS-PAGE using precast
gels (SPU-15S; Atto), and transferred onto PVDF
membranes. The anti-cytochrome c antibody was
used at a dilution of 1:200, followed by incubation
with anti-rabbit Ig-HRP. The signal was visualized
with the ECL kit.
Mitochondorial membrane potential
The mitochondria membrane potential of treated
cells was morphologically detected by a DePsipher
TM
kit (Trevigen, Inc., Gaithersburg, MD, USA). Briefly,
the adherent cells on the Lab-Tek slide chambers
were stained with 5,5?,6,6?,tetrachloro-1,1?,3,3?-tetra-
ethylbenzimidazolyl carbocyanin iodide (DePsipher),
according to the manufacturer’s instructions, in which
it was indicated that the mitochondria would appear
red due to the aggregation of DePsipher in healthy
cells, whereas cells with disrupted mitochondria
potential would appear green, under a fluorescence
microscope.
Results
Cytotoxicity of securioside B against BAC1.2F5
cells
We previously showed that securiosides A and B (the
structure of the securiosides is depicted in Fig. 1A)
induced the apoptotic cell death of murine peritoneal
macrophages in the presence of L-cell-conditioned
medium or M-CSF in vitro.
21 To further characterize
the reaction, it was more suitable to use a cell line
rather than heterogeneous macrophages collected
from animals. Since the compounds did not exert
very weak cytotoxicity for J.774.1 macrophage-like
cells, which are able to grow without the support of
the growth factor, we chose BAC1.2F5 cells, which
require M-CSF or GM-CSF for survival or growth.
22 In
the present study, we used only securioside B,
because the cytotoxic activity of securiosides A and
B towards macrophages or other cells was indistin-
guishable in our previous reports.
20,21
Securioside B induced a marked decrease in the
MTT-reducing activity of the BAC1.2F5 cells from 1
mg/ml of the concentration, in the presence of L-cell-
conditioned medium (Fig. 1B): the dose /response
relationship was quite similar to that of peritoneal
macrophages. To examine whether the compound
caused apoptosis of the cell type, the DNA breaks of
the cells were examined morphologically by the
TUNEL method. As shown in Fig. 2, DNA breaks
were observed in many of the cells cultured with
securioside B plus L-cell-conditioned medium for 3
days, whereas the cells cultured with the latter only
were negative.
Comparison of the cytotoxicity of securiosides B
against BAC1.2F5 cells in the presence of L-cell-
conditioned medium, rM-CSF or rGM-CSF
We had previously obtained the preliminary data that
securiosides A and B induced a decrease in the MTT-
reducing activity of peritoneal macrophages, only
when the cells were cocultured with L-cell-condi-
tioned medium or M-CSF: the macrophages cultured
without any growth factor or with GM-CSF were
much less sensitive to the compounds.
20 However,
the reduction in the MTT assay does not necessarily
reflect cell death, as the inhibition of cell growth also
causes the decrease. Therefore, we next examined
FIG. 1. (A) Structure of securiosides A and B. (B) Dose /response relationship of the cytotoxic effect of securioside B against
the BAC1.2F5 cells. The BAC1.2F5 cells were cultured with 20% L-cell-conditioned medium and the indicated concentrations of
securioside B. MTT-reducing activity was measured on day 3. Bars represent the standard deviation.
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CSF and GM-CSF, as co-factors for the cytotoxicity of
securioside B, comparing the results from the cell-
counting assay and MTT assay.
As shown in Fig. 3A, the BAC1.2F5 cells did not
proliferate without any growth factor(s). The addition
of securioside B alone did not reduce the number of
cells, without any growth factor, up to day 6. In
contrast, the cells proliferated in the presence of L-
cell-conditioned medium and securioside B caused
marked a reduction in the number of these cells from
day 3, and most cells were diminished on day 6: the
compound induced cell death in this condition. On
the other hand, securioside B completely suppressed
the cell growth induced by rM-CSF, but did not
reduce the initial cell number, even on day 6 (Fig.
3B), suggesting that the effect of securioside B in the
presence of M-CSF is cytostatic, rather than cytocidal.
Like M-CSF, rGM-CSF also induced the growth of the
BAC1.2F5 cells
22 (Fig. 3C). Securoside B also sup-
pressed the growth of the cells stimulated by GM-
CSF. However, the cell number at the start of the
culture was scarcely decreased after 6 days of culture
(Fig. 3C).
The dose /response effect of the growth factors
was examined by MTT assay on day 3. The augment-
ing effect of L-cell-conditioned medium was ob-
served at 4% concentration, and was increased to
20% (Fig. 3D). Securioside B caused a marked
decrease in MTT-reducing activity with 4% L-cell-
conditioned medium, and almost complete abroga-
tion was observed with the 20% medium (Fig. 3D),
suggesting extensive cell death occurred in this
condition. rM-CSF induced marginal growth at 10
ng/ml, and the effect reached a plateau at 50 ng/ml.
The suppressive effect of securioside B was seen in
the presence of 50 ng/ml M-CSF; however, it was not
augmented by a higher amount (250 ng/ml) of rM-
CSF (Fig. 3E).
As shown in Fig. 3F, augmentation in the MTT-
reducing activity of rGM-CSF was seen even at 2 ng/
ml. In spite of the potency of the growth-inducing
activity of rGM-CSF, the factor itself induced a lesser
augmentation in the MTT assay than M-CSF, even at
higher concentrations. Securioside B induced a
relatively small degree of decrease in MTT reduction
in the cells cultured together with 2 /250 ng/ml rGM-
CSF. Such a small augmenting effect of GM-CSF and a
weak inhibitory effect of securioside B on GM-CSF-
treated cells in the MTT assay may reflect that the
cells cultured with GM-CSF were small and round in
their morphology, while most of the cells with M-CSF
were large and spread after 3 days (data not shown).
Using peritoneal exudate macrophages we obtained
similar results as described in Fig. 3A /E (data not
shown).
To confirm the results that the effect of securioside
B on cells cultured with M-CSF and/or GM-CSF is
growth inhibitory rather than cytotoxic, and that the
activity of L-cell-conditioned medium in supporting
the cell death-inducing activity of securioside B is
stronger than that of M-CSF and/or GM-CSF, we
FIG. 2. Analysis of the DNA cleavage of the cultured BAC1.2F5 cells. The cells were cultured without (A, B) or with (C, D) 10 mg/
ml securioside B in the presence of 20% L-cell-conditioned medium for 3 days. The cells were stained by the TUNEL method
and observed with phase contrast microscopy (A, C). DNA breaks represented by ﬂuorescein were detected by ﬂuorescence
microscopy (B, D).
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from the treated BAC1.2F5 cells. As shown in Fig. 4,
the majority of the total LDH activity was detected in
the supernatant fraction after being cultured without
any samples for 3 days, while the addition of
securioside B slightly reduced LDH release. In con-
trast, LDH release was reduced to 20 /40% of the total
when the cells were cultured with L-cell-conditioned
medium, M-CSF, and/or GM-CSF. These background
values may have been a result of LDH release from a
damaged population, which arose when the cells
were scrapped with a rubber policeman in the initial
cell preparation. The augmentation of LDH release by
securioside B was the most potent with the addition
of L-cell-conditioned medium, rather than with M-
CSF or GM-CSF. The induction of LDH release by
securioside B was not augmented by the combination
of M-CSF and GM-CSF.
Caspase activation of BAC1.2F5 cells by
securioside B plus L-cell-conditioned medium
We next explored the intracellular pathway, in which
securioside B induces BAC1.2F5 apoptosis in the
presence of L-cell-conditioned medium. It is well
known that caspase-3 is known to be a pivotal
effector caspase in the execution phase of apoptosis:
the proteolytic activity of caspase-3 is produced by
the proteolytic cleavage of procaspase-3, which is
activated by initiator caspases, caspase-8 and cas-
pase-9, located on the upstream of caspase-3.
25
Signal transduction of Fas or tumor necrosis factor-
receptor-induced apoptosis reportedly requires the
activation of caspase-8.
26 Another main pathway
involves cytosolic Apaf-1 and cytochrome c released
from mitochondria, which cooperatively induce the
activation of caspase-9.
27 29 Therefore, to study the
intracellular signal transduction of apoptosis induced
by securioside B, we first measured the enzymatic
FIG. 4. Comparison of the cytolytic activity of securioside B
against the BAC1.2F5 cells in the presence of L-cell-condi-
tioned medium, M-CSF, and/or GM-CSF by LDH release
assay. The BAC1.2F5 cells were cultured with 10 mg/ml
securioside B in the presence of L-cell-conditioned medium
(20%), 100 ng/ml rM-CSF, 100 ng/ml rGM-CSF, or a mixture
of rM-CSF and rGM-CSF (100 ng/ml of each) for 3 days. LDH
release from the cells was described in Materials and
methods. Bars represent the standard deviation.
FIG. 3. Growth curves and MTT-reducing activities of the BAC1.2F5 cells cultured with securioside B in the presence of L-cell-
conditioned medium, M-CSF or GM-CSF. (A) The BAC1.2F5 cells were cultured without (k) or with (m)1 0mg/ml securioside B
in the absence of any macrophage growth-stimulating factor. The growth curves were estimated by cell counting. (B) and (C)
Growth curves of the BAC1.2F5 cells cultured without (open symbols) or with (closed symbols) 10 mg/ml securioside B in the
presence of 20% L-cell-conditioned medium (I, j), 100 ng/ml rM-CSF (2, "), or rGM-CSF (^, '). Bars represent upper and
lower values of duplicate estimations. (D /F) MTT-reducing activities of the cells treated without (open symbols) or with
(closed symbols) 10 mg/ml securioside B in the presence of the indicated concentrations of L-cell-conditioned medium (D), rM-
CSF (E), or rGM-CSF (F). MTT-reducing activity was measured on day 3.
S. Yui et al.
162 Mediators of Inflammation Vol 12  2003activity of caspase-3, caspase-8, and caspase-9 of the
BAC1.2F5 cells treated with the compound in the
presence of L-cell-conditioned medium. As shown in
Fig. 5A, the augmentation of caspase-3 activity by
securioside B was observed on day 2, and more
clearly on day 3. Securioside B also induced an
increase in caspase-9 activity with a similar time
course as caspase-3 (Fig. 5C). In sharp contrast, the
compound did not augment caspase-8 activity on day
2, nor even on day 3 (Fig. 5B).
To confirm the effect of securioside B on the
caspase activation of the BAC1.2F5 cells cultured in
the presence of L-cell-conditioned medium, we next
examined the processing of procaspase-3 and pro-
caspase-8 by western blotting analysis. As shown in
Fig. 6A, the content of procaspase-3 in the cells was
much decreased by the treatment of securioside B,
suggesting that it was cleaved to form the active
enzyme in this condition. On the other hand, the
compound did not reduce the amount of procaspase-
8. These results show good correlation with the
changes in the enzymatic activities of these caspases.
Effect of securioside B on the mitochondria of
BAC1.2F5 cells cultured with L-cell-conditioned
medium
Intracellular signal transduction of many apoptotic
stimuli are known to involve a change in the
permeability transition of the mitochondrial mem-
brane and loss of mitochondrial membrane poten-
tial.
30 Following these changes, several proapoptotic
factors, such as cytochrome c, apoptosis-inducing
factor (AIF), and endonuclease G, are released from
mitochondria.
31,32 Cytochrome c, together with Apaf-
1, activates caspase-9, which in turn activate caspase-
3.
27 29 Since caspase-9 was activated in the BAC1.2F5
cells treated with securioside B and L-cell-condi-
tioned medium, we next examined whether cyto-
chrome c was released to the cytosol in these cells.
As shown in Fig. 6B, cytochrome c was detected in
the cytosolic fraction of the cells cultured with the
compound in the presence of L-cell-conditioned
medium, suggesting that the stimuli of the compound
caused cytochrome c release from the mitochondria.
We next performed a morphological analysis of
mitochondrial membrane potential using a fluores-
cent probe, DePsipher. As shown in Fig. 7, loss of the
membrane potential was observed in most of the
cells cultured with securioside B plus L-cell-condi-
tioned medium.
Discussion
We had previously reported that securiosides induce
macrophage-oriented growth inhibition and apopto-
sis, since these compounds need a 10-fold to 100-fold
higher concentration to exert cytotoxicity against
tumor cell lines.
20 Moreover, securiosides acted on
macrophages only when the cells were cultured with
L-cell-conditioned medium. In the present study, we
characterized the action of the compounds towards
BAC1.2F5 cells in the absence or presence of L-cell-
FIG. 5. Caspase-3, caspase-8, or caspase-9 activities of the BAC1.2F5 cells cultured with securioside B. The BAC1.2F5 cells were
cultured without (white bars) or with 10 mg/ml securioside B (black bars) in the presence of L-cell-conditioned medium (20%).
On the indicated days, the cells were harvested, and caspase-3 activity (A), caspase-8 activity (B), and caspase-9 activity (C)
were measured as described in Materials and methods. Bars represent upper and lower values of duplicate estimations.
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interesting that when BAC1.2F5 cells were cultured
with M-CSF and/or GM-CSF, the compound induced
growth inhibition rather than cell death induction.
Macrophage growth induced by these factors might
be related to the pathological process of many
diseases. For example, M-CSF was reportedly ex-
pressed in atherosclerotic lesions, and the growth of
macrophage-derived foam cells was thought to be
important in the development of these lesions.
7,8
Compounds that have securioside B-like activity
might inhibit macrophage growth without attenuat-
ing their viability in such pathological lesions.
The data that showed that securioside B induced
apoptosis in the presence of L-cell-conditioned
medium suggest that L cells might produce additional
factors that sustain the apoptosis-inducing activity of
securioside B, besides M-CSF. It is considerable that
the growth or functional states of macrophages and
fibroblasts are regulated by each other. For example,
it was recently reported that normal dermal fibro-
blasts express a monocyte-specific chemokine,
BRAK, which may be involved in the generation of
tissue macrophages.
33 Since it has not been reported
whether fibroblast factors contribute to the induction
of macrophage apoptosis, it is important to examine
whether not only L-cell fibrosarcoma cells, but also
normal fibroblasts, produce the factors that support
the apoptosis-inducing activity of securioside B. To
understand the physiological mechanism controlling
the death of macrophages, the nature of the factors
produced by L cells is the next important subject to
be elucidated.
A possible mechanism for the apoptosis induction
by securioside B is that the compound with L-cell-
conditioned medium stimulates the BAC1.2F5 cells to
produce cell death-inducing cytokines, such as tumor
necrosis factor or Fas ligand, in an autocrine or a
paracrine fashion, because Fas /Fas ligand interac-
tions reportedly induced the apoptosis of human
monocytes and macrophages.
34,35 However, this is
not probable, since caspase-8 of the cells, which is
located downstream of Fas or tumor necrosis factor-
receptor stimulation, was not activated by securioside
B plus L-cell-conditioned medium, but the activation
of caspase-3 and caspase-9 was observed.
Many apoptosis-inducing stimuli are known to
engage the mitochondrial (intrinsic) pathway, in
which cytochrome c and multiple proapoptotic
factors are released from the mitochondria.
26,30,31
Cytochrome c reportedly binds Apaf-1 in coopera-
tion with (deoxy)adenosine triphosphate in the
FIG. 7. Analysis of mitochondorial membrane potential of the BAC1.2F5 cells cultured with securioside B. The cells were
cultured without (A) or with (B) 10 mg/ml securioside B in the presence of L-cell-conditioned medium (20%). On day 2, the cells
were stained with DePsipher. The intact mitochondria appear red, whereas mitochondria with disrupted potential appear
green.
FIG. 6. Western blotting analysis of the processing of procaspases and cytosolic cytochrome c. The BAC1.2F5 cells were
harvested on the indicated days, and the processing of procaspase-8 and procaspase-3 (A) or cytosolic cytochrome c (B) were
analyzed.
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activates effector caspases, such as caspase-3.
26 28
Securioside B induced the loss of mitochondrial
membrane potential, cytochrome c release into the
cytosols, and caspase-9 activation of BAC1.2F5 cells
cultured with L-cell-conditioned medium, suggesting
that the compound induced apotosis through the
mitochondrial pathway. In addition to cytochrome c,
multiple proapoptotic or antiapoptotic factors are
released from mitochondria. Among these, AIF and
endonuclease G reportedly induce apoptosis without
the mediation of caspases.
30,31 We observed that
apoptosis induction by securioside-B plus L-cell-
conditioned medium was not inhibited by a pan-
caspase inhibitor, Z-VAD-fmk (data not shown),
suggesting that the postmitochondorial mechanism
included not only caspase-9, caspase-3 and other
caspases, but also caspase-independent molecules,
such as AIF. Additional experiments are needed to
uncover the mitochondrial factors that are essential
for the execution of apoptosis.
The upstream events that induce a loss of mito-
chondrial membrane potential are still unknown.
One possibility is that securioside B inhibits the
intracellular signal transduction pathway of M-CSF
and, in concert with this inhibition, factors other than
M-CSF in L-cell-conditioned medium might produce
additive signals to affect the mitochondria. Therefore,
it is important to elucidate the point of action of the
compound in the inhibition of the growth-inducing
activity of M-CSF. It was recently reported that the
addition of a ganglioside (GD3) to intact cells
induced apoptosis, and GD3 directly induced cyto-
chrome c release from isolated mitochondria.
36 Since
securioside B is an amphipatic molecule, possibly
having micelle formation characters as gangliosides,
an alternative possibility is that securioside B was
incorporated by the macrophages and recruited into
the mitochondrial membrane, which resulted in
inducing mitochondrial permeability transition. In
our preliminary result, 100 mg/ml securioside B
induced cytochrome c release from the mitochondria
isolated from the BAC1.2F5 cells (data not shown).
M-CSF or the other factors in L-cell-conditioned
medium might augment securioside B incorporation
by macrophages.
The mechanism controlling the life span of inflam-
matory macrophages in vivo is obscure. We recently
reported that enterolosaponins A and B, novel
triterpene saponins, also exerted macrophage-or-
iented cytotoxicity.
37 It is possible that securiosides,
or other saponins, mimic unidentified physiological
molecules having regulatory activity for macrophage
growth or survival, which exist endogenously or are
derived from microorganisms. The results described
here might provide clues to exploring pharmacolo-
gical manipulations, as well as the physiological
control mechanism of the life span or the growth
state of peripheral macrophages.
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